培训课件-阿尔马尔在肾内科的应用.ppt

下载文档

6
0
约1.72万字
约 51页
2016-10-19 发布于浙江
举报
版权申诉
保障服务

培训课件-阿尔马尔在肾内科的应用.ppt

1、本文档共51页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

* 表1　K/DOQ I指南中CKD的分期(年龄≥20岁) 分期描述 GFR (mL /min) 发生率(% ) 1 肾损伤, GFR正常或升高 ≥90 3.3 2 肾损伤, GFR轻度下降 60～89 3.0 3 GFR中度下降 30～59 4.3 4 GFR严重下降 15～29 0.2 5 肾衰竭 15或透析 0.1 * * * Proteinuria 蛋白尿. * Hypertension is common in CKD, and is a risk factor for faster progression of kidney disease and development and worsening of CVD. * Results: The prevalence of CKD in the US adult population was 11% (19.2 million). By stage, an estimated 5.9 million individuals (3.3%) had stage 1 (persistent albuminuria with a normal GFR), 5.3 million (3.0%) had stage 2 (persistent albuminuria with a GFR of 60 to 89 mL/min/1.73 m2), 7.6 million (4.3%) had stage 3 (GFR, 30 to 59 mL/min/1.73 m2), 400,000 individuals (0.2%) had stage 4 (GFR, 15 to 29 mL/min/1.73 m2), and 300,000 individuals (0.2%) had stage 5, or kidney failure. Aside from hypertension and diabetes, age is a key predictor of CKD, and 11% of individuals older than 65 years without hypertension or diabetes had stage 3 or worse CKD. Compared with GFR estimates, CCr estimates showed a steeper decline with age and were lower in non-Hispanic blacks. 表1　K/DOQ I指南中CKD的分期(年龄≥20岁) 分期描述 GFR (mL /min) 发生率(% ) 1 肾损伤, GFR正常或升高 ≥90 3.3 2 肾损伤, GFR轻度下降 60～89 3.0 3 GFR中度下降 30～59 4.3 4 GFR严重下降 15～29 0.2 5 肾衰竭 15或透析 0.1 Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey☆[Am J Kidney Dis 41:1-12.] * * 其中共识精读，包括药理特征、作用机制、治疗特点、临床适应症等内容。 * 腓总神经肌肉交感神经活性 MSNA是反映交感